156 related articles for article (PubMed ID: 12903016)
21. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
Carver JR; Shapiro CL; Ng A; Jacobs L; Schwartz C; Virgo KS; Hagerty KL; Somerfield MR; Vaughn DJ;
J Clin Oncol; 2007 Sep; 25(25):3991-4008. PubMed ID: 17577017
[TBL] [Abstract][Full Text] [Related]
22. Late complications of therapy of Hodgkin's disease: prevention and management.
Ng AK; Mauch PM
Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
[TBL] [Abstract][Full Text] [Related]
23. Measuring postirradiation subcutaneous soft-tissue fibrosis: state-of-the-art and future directions.
Davis AM; Dische S; Gerber L; Saunders M; Leung SF; O'Sullivan B
Semin Radiat Oncol; 2003 Jul; 13(3):203-13. PubMed ID: 12903010
[TBL] [Abstract][Full Text] [Related]
24. Genetic susceptibility to late normal tissue injury.
Travis EL
Semin Radiat Oncol; 2007 Apr; 17(2):149-55. PubMed ID: 17395045
[TBL] [Abstract][Full Text] [Related]
25. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
Mehta V
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy-induced thyroid disorders.
Jereczek-Fossa BA; Alterio D; Jassem J; Gibelli B; Tradati N; Orecchia R
Cancer Treat Rev; 2004 Jun; 30(4):369-84. PubMed ID: 15145511
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
[TBL] [Abstract][Full Text] [Related]
28. [The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance].
Rübe CE; Rodemann HP; Rübe C
Strahlenther Onkol; 2004 Sep; 180(9):541-9. PubMed ID: 15378184
[TBL] [Abstract][Full Text] [Related]
29. Fatigue in the radiation therapy patient: current management and investigations.
Jacobsen PB; Thors CL
Semin Radiat Oncol; 2003 Jul; 13(3):372-80. PubMed ID: 12903024
[TBL] [Abstract][Full Text] [Related]
30. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
[TBL] [Abstract][Full Text] [Related]
31. [Role of endothelium in radiation-induced normal tissue damages].
Milliat F; François A; Tamarat R; Benderitter M
Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):139-48. PubMed ID: 18579118
[TBL] [Abstract][Full Text] [Related]
32. Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool?
Hoeller U; Bonacker M; Bajrovic A; Alberti W; Adam G
Strahlenther Onkol; 2004 Oct; 180(10):650-4. PubMed ID: 15480514
[TBL] [Abstract][Full Text] [Related]
33. The role of pentoxifylline as a modifier of radiation therapy.
Nieder C; Zimmermann FB; Adam M; Molls M
Cancer Treat Rev; 2005 Oct; 31(6):448-55. PubMed ID: 16225996
[TBL] [Abstract][Full Text] [Related]
34. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.
Bentzen SM
Nat Rev Cancer; 2006 Sep; 6(9):702-13. PubMed ID: 16929324
[TBL] [Abstract][Full Text] [Related]
35. [Current status and measures for lung injuries in cancer treatment].
Kudoh S; Yoshimura A
Gan To Kagaku Ryoho; 2004 May; 31(5):679-84. PubMed ID: 15170972
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy: long-term effects on gastrointestinal function.
Yeoh E
Curr Opin Support Palliat Care; 2008 Mar; 2(1):40-4. PubMed ID: 18685393
[TBL] [Abstract][Full Text] [Related]
37. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
38. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
39. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
[TBL] [Abstract][Full Text] [Related]
40. Advances in pathogenic mechanisms and management of radiation-induced fibrosis.
Wang B; Wei J; Meng L; Wang H; Qu C; Chen X; Xin Y; Jiang X
Biomed Pharmacother; 2020 Jan; 121():109560. PubMed ID: 31739160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
